Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Blood‐based multivariate methylation risk score for cognitive impairment and dementia

28 Aug 2024

Abstract excerpt

Abstract INTRODUCTION The established link between DNA methylation and pathophysiology of dementia, along with its potential role as a molecular mediator of lifestyle and environmental influences, positions blood‐derived DNA methylation as a promising tool for early dementia risk detection. METHODS In conjunction with an extensive array of machine learning techniques, we employed whole blood genome‐wide DNA...

Topics

Join the communities discussing this publication.

Dementia and Cognitive Impairment Research
Epigenetics and DNA Methylation
Genomics and Rare Diseases

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 39193899
DOI: 10.1002/alz.14061

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Blood‐based multivariate methylation risk score for cognitive impairment and dementiaPMID 39193899Read ↗

Epigenome-wide analyses identify DNA methylation signatures of dementia riskSemantic proximity Read ↗

Blood DNA methylation signatures to detect dementia prior to overt clinical symptomsSemantic proximity Read ↗

Whole genome methylation sequencing in blood from persons with mild cognitive impairment and dementia due to Alzheimer's disease identifies cognitive statusSemantic proximity Read ↗

Whole genome methylation sequencing in blood from persons with mild cognitive impairment and dementia due to Alzheimer’s disease identifies cognitive statusSemantic proximity Read ↗

Whole genome methylation sequencing in blood identifies extensive differential DNA methylation in late‐onset dementia due to Alzheimer's diseaseSemantic proximity Read ↗

Blood-based epigenome-wide analyses of cognitive abilitiesSemantic proximity Read ↗

Association of peripheral blood DNA methylation level with Alzheimer’s disease progressionSemantic proximity Read ↗

Distinct CSF biomarker-associated DNA methylation in Alzheimer's disease and cognitively normal subjectsSemantic proximity Read ↗

Epigenetic genes are differentially methylated in the blood of persons with mild cognitive impairment and Alzheimer’s diseaseSemantic proximity Read ↗

Distinct CSF biomarker-associated DNA methylation in Alzheimer’s disease and cognitively normal subjectsSemantic proximity Read ↗

Sixteen-year longitudinal evaluation of blood-based DNA methylation biomarkers for early prediction of Alzheimer’s diseaseSemantic proximity Read ↗

Complementary value of molecular, phenotypic and functional aging biomarkers in dementia predictionSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.